Sanofi's Consumer Healthcare Division Chattem Announces Nasacort® Allergy 24HR Nasal Spray Now Available Without a Prescription in the U.S.
Etripamil Nasal Spray Shows Promise for AF Patients With Rapid Ventricular Rate | tctmd.com
Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS‐52 is unaffected by eosinophilic status - Fujieda - 2022 - Allergy - Wiley Online Library
Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient‐reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS‐24 and
Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS‐52 is unaffected by eosinophilic status - Fujieda - 2022 - Allergy - Wiley Online Library